Sio Gene Therapies, Inc. (SIOX): Price and Financial Metrics


Sio Gene Therapies, Inc. (SIOX): $0.45

0.00 (-0.31%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SIOX to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

SIOX Stock Price Chart Interactive Chart >

Price chart for SIOX

SIOX Price/Volume Stats

Current price $0.45 52-week high $0.86
Prev. close $0.46 52-week low $0.23
Day low $0.44 Volume 289,200
Day high $0.46 Avg. volume 355,788
50-day MA $0.41 Dividend yield N/A
200-day MA $0.35 Market Cap 33.11M

Sio Gene Therapies, Inc. (SIOX) Company Bio


Sio Gene Therapies, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops gene therapies that transform the treatment of serious neurodegenerative diseases. Sio Gene Therapies serves customers worldwide.


SIOX Latest News Stream


Event/Time News Detail
Loading, please wait...

SIOX Latest Social Stream


Loading social stream, please wait...

View Full SIOX Social Stream

Latest SIOX News From Around the Web

Below are the latest news stories about SIO GENE THERAPIES INC that investors may wish to consider to help them evaluate SIOX as an investment opportunity.

Have you been able to find a good deal on Sio Gene Therapies Inc.’s shares?

A share of Sio Gene Therapies Inc. (NASDAQ:SIOX) closed at $0.44 per share on Tuesday, up from $0.44 day before. While Sio Gene Therapies Inc. has overperformed by 0.07%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, SIOX fell by -67.41%, with highs and lows ranging […]

US Post News | December 28, 2022

The Sio Gene Therapies Inc. (SIOX) had a good session last reading, didn’t it?

The share price of Sio Gene Therapies Inc. (NASDAQ:SIOX) rose to $0.31 per share on Tuesday from $0.30. While Sio Gene Therapies Inc. has overperformed by 2.67%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, SIOX fell by -78.00%, with highs and lows ranging from $1.52 […]

US Post News | December 14, 2022

Sio Gene Therapies Inc. Announces Board Approval of Plan of Complete Liquidation and Dissolution

NEW YORK, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (Nasdaq:SIOX) today announced that its Board of Directors has determined, after extensive and careful consideration of potential strategic alternatives, that it is in the best interests of the Company and its shareholders to dissolve the Company and liquidate its assets, including its subsidiaries. "After evaluating the Company's strategic options, the Board of Directors unanimously concluded that it is in the best interests of

Yahoo | December 14, 2022

After Jumping 2.96% During The Past Week, Should You Still Buy Sio Gene Therapies Inc. (NASDAQ: SIOX)?

Sio Gene Therapies Inc. (NASDAQ:SIOX)’s traded shares stood at 0.51 million during the last session, with the company’s beta value hitting 1.58. At the close of trading, the stock’s price was $0.32, to imply an increase of 0.95% or $0.0 in intraday trading. The SIOX share’s 52-week high remains $1.53, putting it -378.12% down since … After Jumping 2.96% During The Past Week, Should You Still Buy Sio Gene Therapies Inc. (NASDAQ: SIOX)? Read More »

Marketing Sentinel | December 3, 2022

Sio Gene Therapies Inc. (SIOX) can excel with these strategies

In Thursday’s session, Sio Gene Therapies Inc. (NASDAQ:SIOX) marked $0.32 per share, up from $0.31 in the previous session. While Sio Gene Therapies Inc. has overperformed by 2.96%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, SIOX fell by -79.28%, with highs and lows ranging from […]

US Post News | December 2, 2022

Read More 'SIOX' Stories Here

SIOX Price Returns

1-mo 1.88%
3-mo 48.71%
6-mo 31.35%
1-year -43.71%
3-year -89.77%
5-year N/A
YTD 3.45%
2022 -66.28%
2021 -53.60%
2020 -45.70%
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6901 seconds.